Metronidazole tablets can treat trichomoniasis, amoebiasis (e.g., amoebic liver abscess, pleural amoebiasis), pouch disease, and the treatment of a wide range of anaerobic infections, including oral infections caused by anaerobic bacteria (e.g., gingivitis, periodontitis, pericoronitis, oral ulcers, etc.), sepsis, abdominal infections, pelvic infections, gynecological infections, and bone and joint infections. Metronidazole has a good antibacterial effect on most anaerobic bacteria, and also has a strong effect on a variety of pathogens such as Trichomonas, Amoeba, etc. It may interfere with bacterial growth, reproduction, and ultimately bacterial death by inhibiting bacterial synthesis; it also inhibits the redox reaction of Amoeba as well as the enhanced trichomonocidal effect. The dosage of metronidazole tablets must be determined in the context of clinical as well as patient conditions, etc. Please refer to the guidance of your physician in an interview. It must be noted that metronidazole is contraindicated in persons with central nervous system disorders and blood disorders, and patients should inform the physician of their medical history truthfully during the visit. Discomfort in the digestive tract may occur during dosing, possibly nausea, vomiting, loss of appetite, abdominal cramps, etc., and generally does not affect treatment. Those who are seriously intolerant may consult a physician to adjust the medication regimen. A few patients may also experience headache, dizziness, rash, itching, metallic taste in the mouth, etc., which generally do not affect the treatment, but serious cases should consult a physician or pharmacist.